The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection
Ebola virus (EBOV) is a highly pathogenic virus causing severe hemorrhagic fever with a high case fatality rate of 50% - 90% in humans. Without an approved vaccine or treatments, Ebola outbreak management has been limited to palliative care and barrier methods to prevent transmission. These approaches, however, have yet to end the 2014 outbreak of Ebola after its prolonged presence in West Africa. As with the increase of outbreaks, a significant effort has been made to develop promising countermeasures for the prevention and treatment of Ebola virus infection. In this review, development of therapeutics and potential inhibitors for Ebola virus infection will be discussed..
| Media Type: |
Article |
|---|
| Year of Publication: |
2017 |
|---|---|
| Publication: |
2017 |
| Contained In: |
To Main Record - volume:17 |
|---|---|
| Contained In: |
Current topics in medicinal chemistry - 17(2017), 3, Seite 361-370 |
| Language: |
English |
|---|
| Contributors: |
Wenjiao Wu [Author] |
|---|
| Links: |
|---|
| BKL: |
|---|
| Supporting institution / Project title: |
|
|---|
| PPN (Catalogue-ID): |
OLC1989809839 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1989809839 | ||
| 003 | DE-627 | ||
| 005 | 20230515132331.0 | ||
| 007 | tu | ||
| 008 | 170207s2017 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a PQ20170206 |
| 035 | |a (DE-627)OLC1989809839 | ||
| 035 | |a (DE-599)GBVOLC1989809839 | ||
| 035 | |a (PRQ)b1541-935a3d2636cb3f70001ff25bd81480399ae635cd9bcbc05d3aad84b8fb91abdf0 | ||
| 035 | |a (KEY)0446467220170000017000300361drugtargetsandantiviralmoleculesfortreatmentofebol | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 540 |q DNB |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 0 | |a Wenjiao Wu |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Ebola virus (EBOV) is a highly pathogenic virus causing severe hemorrhagic fever with a high case fatality rate of 50% - 90% in humans. Without an approved vaccine or treatments, Ebola outbreak management has been limited to palliative care and barrier methods to prevent transmission. These approaches, however, have yet to end the 2014 outbreak of Ebola after its prolonged presence in West Africa. As with the increase of outbreaks, a significant effort has been made to develop promising countermeasures for the prevention and treatment of Ebola virus infection. In this review, development of therapeutics and potential inhibitors for Ebola virus infection will be discussed. | ||
| 700 | 0 | |a Shuwen Liu |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Current topics in medicinal chemistry |d Hilversum [u.a.] : Bentham Science Publ., 2001 |g 17(2017), 3, Seite 361-370 |w (DE-627)338770283 |w (DE-600)2064823-6 |w (DE-576)435515160 |x 1568-0266 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2017 |g number:3 |g pages:361-370 |
| 856 | 4 | 2 | |u http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1568-0266&volume=17&issue=3&spage=361 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 936 | u | w | |d 17 |j 2017 |e 3 |h 361-370 |
| 951 | |a AR | ||
| 952 | |d 17 |j 2017 |e 3 |h 361-370 | ||